Applied Therapeutics, Inc. (APLT) NASDAQ

Currency In USD

AD

Valuation

Market Cap119.47M
Enterprise Value42.87M
P/E Ratio-0.83
PEG Ratio-0.01
Price/Sales Ratio14.86
Price/Book Ratio-26.72
Enterprise/Revenue5.42
Enterprise/EBITDA-0.3

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-18.14
Operating Margin-98.4
AD

Management Effectiveness

Return On Assets-0.53
Return On Equity-0.66

Income Statement

Revenue455,000
Revenue/Share0.01
Gross Profit-48.29M
EBITDA-105.62M
Net Income-105.62M
Diluted EPS-0.76

Balance Sheet

Total Cash11.95M
Total Cash/Share0.08
Total Debt2.5M
Total Debt/Equity-4.46
Current Ratio0.96
Book Value Per Share-0

Price History

52-Week Change-79.46
52-Week High1.5
52-Week Low0.09
Moving Average 50 Days0.15
Moving Average 200 Days0.46

Statistics

Average Volume15.8M
Shares Outstanding144.3M
% Held by Institutions40.45

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD